Online citations, reference lists, and bibliographies.

FDG-PET/CT As Prognostic Factor And Surveillance Tool For Postoperative Radiation Recurrence In Locally Advanced Head And Neck Cancer

Giwon Kim, Yeon Sil Kim, Eun Ji Han, Ie Ryung Yoo, Jinho Song, Sang-Nam Lee, Jong Hoon Lee, B. O. Choi, Hong-seok Jang, Sei-Chul Yoon
Published 2011 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
Purpose To evaluate the prognostic value of metabolic tumor volume (MTV) and maximum standardized uptake value (SUVmax) on initial positron emission tomography-computed tomography (PET-CT) and investigate the clinical value of SUVmax for early detection of locoregional recurrent disease after postoperative radiotherapy in patients with locally advanced head and neck squamous cell carcinoma (HNSCC). Materials and Methods A total of 100 patients with locally advanced HNSCC received primary tumor excision and neck dissection followed by adjuvant radiotherapy with or without chemotherapy. The MTV and SUVmax were measured from primary sites and neck nodes. The prognostic value of MTV and SUVmax were assessed using initial staging PET/CT (study A). Follow-up PET/CT scan available after postoperative concurrent chemoradiotherapy or radiotherapy were evaluated for the SUVmax value and correlated with locoregional recurrence (study B). A receiver operating characteristic (ROC) curve analysis was used to define a threshold value of SUVmax with the highest accuracy for recurrent disease assessment. Results High MTV (>41 mL) is negative prognostic factor for disease free survival (p = 0.041). Postradiation SUVmax was significantly correlated with locoregional recurrence (hazard ratio, 1.812; 95% confidence interval, 1.361 to 2.413; p < 0.001). A cut-off value of 5.38 from follow-up PET/CT was identified as having maximal accuracy for detecting locoregional recurrence by ROC analysis. Conclusion MTV at staging work-up was significantly associated with disease free survival. The SUVmax value from follow-up PET/CT showed high diagnostic accuracy for the detection of locoregional recurrence in postoperatively irradiated HNSCC.
This paper references
The diagnostic and prognostic ut i l i ty of positron emission tomography/computed tomography-based follow-up after radiotherapy for head and neck cancer
J Kao (2009)
10.1200/JCO.2002.02.590
Diagnostic and Prognostic Value of [18F]Fluorodeoxyglucose Positron Emission Tomography for Recurrent Head and Neck Squamous Cell Carcinoma
Richard J Wong (2002)
10.1200/JCO.2008.19.3300
Prospective risk-adjusted [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer.
Benjamin J. Moeller (2009)
Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma.
Richard J Wong (2002)
10.1016/j.ijrobp.2008.10.060
Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer.
Trang H. La (2008)
10.1016/j.ijrobp.2008.05.004
Pretreatment primary tumor SUVmax measured by FDG-PET and pathologic tumor depth predict for poor outcomes in patients with oral cavity squamous cell carcinoma and pathologically positive lymph nodes.
Chun-ta Liao (2009)
10.1056/NEJMoa032646
Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck.
Jay Scott Cooper (2004)
10.1016/j.ijrobp.2006.03.015
Posttreatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancers.
Regiane S Andrade (2006)
10.1016/j.ijrobp.2008.07.019
Clinical significance of postradiotherapy [18F]-fluorodeoxyglucose positron emission tomography imaging in management of head-and-neck cancer-a long-term outcome report.
Min Yao (2009)
10.2967/jnumed.108.055806
Does 18F-FDG PET/CT Improve the Detection of Posttreatment Recurrence of Head and Neck Squamous Cell Carcinoma in Patients Negative for Disease on Clinical Follow-up?
Ronan Abgral (2009)
10.1016/S0360-3016(03)00757-0
FDG-PET scanning after radiation can predict tumor regrowth three months later.
Izumi Koike (2003)
10.1016/S0360-3016(96)00430-0
Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: final report of a randomized trial.
Jean Marc Bachaud (1996)
Cl inical uti l ity of 18 FFDG PET / CT in assessing the neck after concurrent chemoradiotherapy for Locoregional advanced head and neck cancer
SC Ong (2008)
10.1007/978-88-470-2522-6_28
Diagnostic and Prognostic Value
Joanne D. Schuijf (2012)
10.1016/j.ijrobp.2005.03.066
The role of FDG PET in management of neck metastasis from head-and-neck cancer after definitive radiation treatment.
Min Yao (2005)
10.1016/j.ijrobp.2007.06.038
Utility of PET/CT imaging performed early after surgical resection in the adjuvant treatment planning for head and neck cancer.
Stephanie A. Shintani (2008)
SUVmax value for early detection of recurrence in head and neck cancer www.e-roj
10.1002/hed.20279
Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501).
Jacques Bernier (2005)
Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer.
Heikki Minn (1997)
10.1002/cncr.24493
The diagnostic and prognostic utility of positron emission tomography/computed tomography-based follow-up after radiotherapy for head and neck cancer.
Johnny Kao (2009)
10.1002/hed.20130
Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer.
Sandro Virgilio Porceddu (2005)
10.1016/j.ijrobp.2003.12.039
Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-D-glucose.
Abdelkarim Said Allal (2004)
10.1016/j.ijrobp.2008.09.045
Preoperative [18F]fluorodeoxyglucose positron emission tomography standardized uptake value of neck lymph nodes predicts neck cancer control and survival rates in patients with oral cavity squamous cell carcinoma and pathologically positive lymph nodes.
Chun-ta Liao (2009)
10.1016/j.ijrobp.2007.04.036
Metabolic tumor burden predicts for disease progression and death in lung cancer.
Percy P. Lee (2007)
10.1158/1078-0432.CCR-08-3290
Metabolic Tumor Volume of [18F]-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Predicts Short-Term Outcome to Radiotherapy With or Without Chemotherapy in Pharyngeal Cancer
Man Ki Chung (2009)
10.2967/jnumed.107.044792
Clinical Utility of 18F-FDG PET/CT in Assessing the Neck After Concurrent Chemoradiotherapy for Locoregional Advanced Head and Neck Cancer
Seng Chuan Ong (2008)
10.1200/JCO.2000.18.3.651
Surveillance for recurrent head and neck cancer using positron emission tomography.
Val J. Lowe (2000)



This paper is referenced by
10.2967/jnumed.115.165480
18F-FDG PET/CT: Therapy Response Assessment Interpretation (Hopkins Criteria) and Survival Outcomes in Lung Cancer Patients
Sara Sheikhbahaei (2016)
10.2214/AJR.17.18301
Clinical Practice in PET/CT for the Management of Head and Neck Squamous Cell Cancer.
Reema Goel (2017)
10.1007/S00761-014-2813-0
Tumorvolumenbestimmung: Anforderungen der Strahlentherapie an die moderne radiologische Bildgebung
R Bütof (2015)
10.2214/AJR.15.15730
Therapy Response Assessment and Patient Outcomes in Head and Neck Squamous Cell Carcinoma: FDG PET Hopkins Criteria Versus Residual Neck Node Size and Morphologic Features.
Rick Arthur Wray (2016)
10.4103/bbrj.bbrj_75_18
Prognostic value of 18F-fluorodeoxyglucose-positron emission tomography/computed tomography scan volumetric parameters in head-and-neck cancer patients after treatment
Mehrdad Bakhshyesh Karam (2018)
10.2214/AJR.13.11654
FDG volumetric parameters and survival outcomes after definitive chemoradiotherapy in patients with recurrent head and neck squamous cell carcinoma.
Vasavi Paidpally (2014)
10.1002/hed.25513
18F‐FDG PET/CT for locoregional surveillance following definitive treatment of head and neck cancer: A meta‐analysis of reported studies
Erin T Wong (2019)
10.1111/1754-9485.12496
A review of the predictive role of functional imaging in patients with mucosal primary head and neck cancer treated with radiation therapy
Myo Min (2017)
10.3978/j.issn.1000-9604.2014.01.06
Prognostic value of post-treatment (18)F-FDG PET/CT for advanced head and neck cancer after combined intra-arterial chemotherapy and radiotherapy.
Kimiteru Ito (2014)
10.1016/j.cpet.2014.12.001
18F FDG PET/CT and Head and Neck Cancer: Patient Management and Outcomes.
Sara Sheikhbahaei (2015)
10.3857/roj.2012.30.4.173
Prognostic value of 18F-fluorodeoxyglucose positron emission tomography, computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with pathologically positive neck lymph node
Eunjin Jwa (2012)
10.1002/hed.23988
Fate of patients with nasopharyngeal cancer who developed distant metastasis as first failure after definitive radiation therapy.
Ji Hyun Chang (2016)
10.2967/jnumed.113.133801
Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis in Head and Neck Cancer: A Systematic Review and Meta-Analysis
Kyoungjune Pak (2014)
10.1007/978-3-662-48842-3_19
PET/CT in der Strahlentherapie
Matthias Lampe (2020)
10.1259/BJR.20160217
Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: the point of view of the radiation oncologist.
Jon Cacicedo (2016)
10.1007/s00405-018-05272-w
Performance of whole-body 18F-FDG PET/CT as a posttreatment surveillance tool for sinonasal malignancies
Kerem Ozturk (2018)
10.1017/S0022215115001139
p16 status and interval neck dissection findings after a 'clinically complete response' to chemoradiotherapy in oropharyngeal squamous cell carcinoma.
Mohammed S. Miah (2015)
10.1007/s00259-017-3713-5
Clinical impact of PET/CT imaging after adjuvant therapy in patients with oral cavity squamous cell carcinoma
Huan-Chun Lin (2017)
10.2214/AJR.14.14166
Diagnostic Accuracy of Follow-Up FDG PET or PET/CT in Patients With Head and Neck Cancer After Definitive Treatment: A Systematic Review and Meta-Analysis.
Sara Sheikhbahaei (2015)
Positron Emission Tomography and StageMigration in Head and Neck Cancer
Noam A Vanderwalde (2014)
10.1097/MD.0000000000016327
Metabolic tumor volume and conformal radiotherapy based on prognostic PET/CT for treatment of nasopharyngeal carcinoma
Zhaodong Fei (2019)
10.1634/theoncologist.2013-0068
Early detection of recurrent disease by FDG-PET/CT leads to management changes in patients with squamous cell cancer of the head and neck.
Lale Kostakoğlu (2013)
10.1001/jamaoto.2014.812
Positron emission tomography and stage migration in head and neck cancer.
Noam A. VanderWalde (2014)
10.1097/RLU.0000000000000613
Prognostic Value of SUVmean in Oropharyngeal and Hypopharyngeal Cancers: Comparison with SUVmax and Other Volumetric Parameters of 18F-FDG PET
Kyoungjune Pak (2015)
10.1007/s00259-016-3584-1
Nodal parameters of FDG PET/CT performed during radiotherapy for locally advanced mucosal primary head and neck squamous cell carcinoma can predict treatment outcomes: SUVmean and response rate are useful imaging biomarkers
Peter Lin (2016)
10.1200/JCO.2013.31.15_SUPPL.6018
Positron emission tomography and stage migration for head and neck cancer.
Noam A Vanderwalde (2013)
10.5772/57127
PET – Assessment of Oncologic Treatment Response
Inga Siiner Grills (2013)
10.1186/s12885-016-2147-y
Predictive and prognostic value of PET/CT imaging post-chemoradiotherapy and clinical decision-making consequences in locally advanced head & neck squamous cell carcinoma: a retrospective study
Ryul Kim (2016)
10.1002/hed.25337
Pretreatment metabolic tumor volume as a prognostic factor in HPV‐associated oropharyngeal cancer in the context of AJCC 8th edition staging
John M Floberg (2018)
10.1016/j.joms.2014.06.419
Positron emission tomography-computed tomography: a superior and one-stop shop modality for treated head and neck carcinoma compared with conventional tomography.
Vijay Kumar Ichpujani (2014)
10.4143/crt.2015.379
Predictors of Distant Metastasis after Radical Surgery Followed by Postoperative Radiotherapy with or without Chemotherapy for Oropharyngeal Cancer
Mi Joo Chung (2016)
18 F-FDG PET / CT : Therapy Response Assessment Interpretation ( Hopkins Criteria ) and Survival Outcomes in Lung Cancer Patients
Sara Sheikhbahaei (2016)
See more
Semantic Scholar Logo Some data provided by SemanticScholar